Ligand Pharma (LGND) Tops Q2 EPS by 60c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. AMZN
2. INTC
3. RDDT
4. COIN
5. PINS
6. FSLR
7. DASH
8. SYK
9. SBUX
10. ALNY

Go back to Ligand Pharma (LGND) Tops Q2 EPS by 60c

Ligand Reports Second Quarter 2022 Financial Results

August 8, 2022 4:01 PM EDT

Raises 2022 Financial Guidance

Conference Call Begins at 4:30 p.m. Eastern Time Today

EMERYVILLE, Calif.--(BUSINESS WIRE)-- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three and six months ended June 30, 2022 and provided an operating forecast and program updates. Ligand management will host a conference call today beginning at 4:30 p.m. Eastern time to discuss this announcement and answer questions.

2022 continues to be an outstanding year for Ligand, in particular as royalties from our Pelican Expression Technology platform grow into... More